Study of physicochemical properties-antitubercular activity relationship of naphthalene-1,4-dione analogs: A qsar approach

Chemical Papers

Volumn 63, Issue 6, 2009, Pages 723-730

  Gupta, Revathi A ^a   Gupta, Arun Kumar ^b   Soni, Love Kumar ^a   Kaskhedikar, Satish G ^a  

^a SHRI G S INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b Smriti College of Pharmaceutical Education   (India)

Author keywords

Antitubercular activity; Cytotoxicity; Naphthalene 1,4 diones; QSAR

Indexed keywords

EID: 70350370457     PISSN: 03666352     EISSN: 13369075     Source Type: Journal    
DOI: 10.2478/s11696-009-0080-0     Document Type: Article

References (22)

1. CambridgeSoft Corporation. (2001). CS ChemOffice 2001, Version Ultra 6.0 [computer software]. Cambridge, MA: CambridgeSoft Corporation.
2. Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003). The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archive of Internal Medicine, 163, 1009-1021.
3. Dick, T. (2001). Dormant tubercle bacilli: the key to more effective TB chemotherapy? Journal of Antimicrobial Chemotherapy, 47, 117-118. DOI: 10.1093/jac/47.1.117.
4. Fedorowicz, A., Zheng, L., Singh, H., & Demchuk, E. (2004). QSAR study of skin sensitization using local lymph node assay data. International Journal of Molecular Science, 5, 56-66. DOI: 10.3390/i5020056.
5. Gasteiger, J., Sadowski, J., Schuur, J. H., Selzer, P., Steinhauer, L., & Steinhauer, V. (1996). Chemical information in 3D space. Journal of Chemical Information and Computer Sciences, 36, 1030-1037. DOI: 10.1021/ci960343+.
6. Gomez, J. E., & McKinney, J. D. (2004). M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis, 84, 29-44. DOI: 10.1016/j.tube.2003.08.003.
7. Gupta, A. K., Babu, M. A., & Kaskhedikar, S. G. (2004). VALSTAT: Validation program for quantitative structure activity relationship. Indian Journal of Pharmaceutical Science, 66, 396-402.
8. Gupta, R. A., Gupta, A. K., Soni, L. K., & Kaskhedikar, S. G. (2007). Exploration of physicochemical properties and molecular modeling studies of furanylamide analogs as antituberculosis agents. QSAR and Combinatorial Science, 26, 897-907. DOI: 10.1002/qsar.200630141.
9. Hansch, C., & Leo, A. J. (1979). Substituent constants for correlation analysis in chemistry and biology. New York: John Wiley & Sons, Inc.
10. Hemmer, M. C., & Gasteiger, J. (2000). Prediction of three-dimensional structure using information from infrared spectra. Analytica Chimica Acta, 420, 145-154. DOI: 10.1016/S0003-2670(00)00876-X.
11. Hemmer, M. C., Steinhauer, V., & Gasteiger, J. (1999). Deriving the 3D structure of organic molecules from their infrared spectra. Vibrational Spectroscopy, 19, 151-164. DOI: 10.1016/S0924-2031(99)00014-4.
12. Mahapatra, A., Mativandlela, S. P. N., Binneman, B., Fourie, P. B., Hamilton, C. J., Meyer, J. J. M., van der Kooy, F., Houghton, P., & Lall, N. (2007). Activity of 7-methyljuglone derivatives against obacterium tuberculosisand as subversive substrates for mycothiol disulfide reductase. Bioorganic & Medicinal Chemistry, 15, 7638-7646. DOI: 10.1016/j.bmc.2007.08.064.
13. Pozniak, A. (2001). Multidrug-resistant tuberculosis and HIV infection. Annals of the New York Academy of Sciences, 953b, 192-198. DOI: 10.1111/j.1749-6632.2001.tb11377.x.
14. Schuur, J., & Gasteiger, J. (1997). Infrared spectra simulation of substituted benzene derivatives on the basis of a 3D structure representation. Analytical Chemistry, 69, 2398-2405. DOI: 10.1021/ac9611071.
15. Schuur, J. H., Selzer, P., & Gasteiger, J. (1996). The coding of the three-dimensional structure of molecules by molecular transforms and its application to structure-spectra correlations and studies of biological activity. Journal of Chemical Information and Computer Sciences, 36, 334-344. DOI: 10.1021/ci950164c.
16. Skagerberg, B., Bonelli, D., Clementi, S., Cruciani, G., & Ebert, C. (1989). Principal properties for aromatic substituents. A multivariate approach for design in QSAR. Quantitative Structure-Activity Relationships, 8, 32-38. DOI: 10.1002/qsar.19890080105.
17. Smith, C. V., Huang, C. C., Miczak, A., Russell, D. G., Sacchettini, J. C., & Höner zu Bentrup, K. (2003). Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis. Journal of Biological Chemistry, 278, 1735-1743. DOI: 10.1074/jbc.M209248200.
18. Todeschini, R., & Consonni, V. (2000). Handbook of molecular descriptors. Weinheim: Wiley-VCH.
19. Todeschini, R., & Consonni, V. (2001). DRAGON-software for the calculation of molecular descriptors, rel. 1.12 for Windows [computer software].
20. Wayne, L. G. (1994). Dormancy of Mycobacterium tuberculosis and latency of disease. European Journal of Clinical Microbiology & Infectious Diseases, 13, 908-914. DOI: 10.1007/BF02111491.
21. Wayne, L. G., & Hayes, L. G. (1996). An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of non-replicating persistence. Infection and Immunity, 64, 2062-2069.
22. WHO (2009). Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009 (WHO/HTM/TB/2009. 411). Geneva: World Health Organization.